Literature DB >> 2881317

The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?

J L Waddington, A G Molloy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881317     DOI: 10.1007/bf00690944

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  6 in total

1.  Dopamine receptor function and spontaneous orofacial dyskinesia in rats during 6-month neuroleptic treatments.

Authors:  J L Waddington; A J Cross; S J Gamble; R C Bourne
Journal:  Adv Biochem Psychopharmacol       Date:  1983

2.  Duration of treatment relationships for involuntary movements (tardive dyskinesia): concordance between cross-sectional, clinical, and longitudinal animal studies?

Authors:  J L Waddington; A G Molloy
Journal:  Arch Gen Psychiatry       Date:  1986-02

3.  Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment.

Authors:  J L Waddington; A J Cross; S J Gamble; R C Bourne
Journal:  Science       Date:  1983-04-29       Impact factor: 47.728

4.  Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.

Authors:  J L Waddington; H A Youssef; A G Molloy; K M O'Boyle; M T Pugh
Journal:  J Clin Psychiatry       Date:  1985-04       Impact factor: 4.384

5.  Tardive dyskinesia in the aged. Duration of treatment relationships.

Authors:  L M Toenniessen; D E Casey; B H McFarland
Journal:  Arch Gen Psychiatry       Date:  1985-03

Review 6.  Acute dystonia induced by neuroleptic drugs.

Authors:  N M Rupniak; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  6 in total
  10 in total

Review 1.  Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.

Authors:  J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.

Authors:  R E See; G Ellison
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 3.  The ageing brain, neuroleptic drugs and the enigma of schizophrenia.

Authors:  J L Waddington
Journal:  Ir J Med Sci       Date:  1988-05       Impact factor: 1.568

4.  Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.

Authors:  R E Steinpreis; P Baskin; J D Salamone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.

Authors:  P Collins; C L Broekkamp; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities.

Authors:  S Mithani; S Atmadja; K G Baimbridge; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Drug-induced purposeless chewing: animal model of dyskinesia or nausea?

Authors:  N M Rupniak; S J Tye; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.

Authors:  R E See; E D Levin; G D Ellison
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Interaction between chronic amphetamine and neuroleptic treatments on oral behavior in rats.

Authors:  A D Levy; G D Ellison
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.